BlackRock Inc. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 148 filers reported holding ACORDA THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$756,000
+35.2%
1,093,359
+0.7%
0.00%
Q3 2020$559,000
-33.5%
1,086,230
-5.2%
0.00%
Q2 2020$840,000
-87.7%
1,145,305
-84.4%
0.00%
Q1 2020$6,829,000
-57.3%
7,321,920
-6.6%
0.00%
-100.0%
Q4 2019$15,991,000
-28.9%
7,839,176
+0.1%
0.00%0.0%
Q3 2019$22,485,000
-58.2%
7,834,694
+11.8%
0.00%
-50.0%
Q2 2019$53,742,000
-39.9%
7,006,848
+4.2%
0.00%
-50.0%
Q1 2019$89,373,000
-14.0%
6,724,897
+0.8%
0.00%
-20.0%
Q4 2018$103,948,000
-9.4%
6,671,846
+14.2%
0.01%0.0%
Q3 2018$114,768,000
-41.8%
5,840,738
-14.9%
0.01%
-44.4%
Q2 2018$197,035,000
+28.9%
6,865,313
+6.3%
0.01%
+28.6%
Q1 2018$152,811,000
+10.3%
6,461,423
+0.0%
0.01%0.0%
Q4 2017$138,564,000
-6.7%
6,459,742
+2.9%
0.01%0.0%
Q3 2017$148,511,000
+17.5%
6,279,562
-2.1%
0.01%0.0%
Q2 2017$126,421,000
-6.3%
6,417,336
-0.1%
0.01%0.0%
Q1 2017$134,932,000
+69452.6%
6,425,256
+62573.2%
0.01%
Q4 2016$194,000
-47.6%
10,252
-42.2%
0.00%
-100.0%
Q3 2016$370,000
+11.1%
17,735
+35.7%
0.00%0.0%
Q2 2016$333,000
+326.9%
13,065
+342.1%
0.00%
Q1 2016$78,000
+36.8%
2,955
+120.7%
0.00%
Q4 2015$57,000
+96.6%
1,339
+21.8%
0.00%
Q3 2015$29,000
-80.5%
1,099
-75.3%
0.00%
Q2 2015$149,000
-57.7%
4,446
-58.0%
0.00%
Q1 2015$352,000
+278.5%
10,581
+363.1%
0.00%
Q4 2014$93,000
+20.8%
2,2850.0%0.00%
Q3 2014$77,000
+97.4%
2,285
+97.7%
0.00%
Q2 2014$39,000
-98.7%
1,156
-98.6%
0.00%
-100.0%
Q1 2014$3,110,000
+39.3%
82,054
+7.3%
0.01%
+25.0%
Q4 2013$2,233,000
+190.4%
76,454
+239.8%
0.00%
+300.0%
Q3 2013$769,000
+7.7%
22,499
+3.9%
0.00%0.0%
Q2 2013$714,00021,6480.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders